Search results for: Giancarlo Piovaccari

Items from 1 to 17 out of 17 results

article

Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices

Gianni Dall'Ara, Andrea Santarelli, Antonio Marzocchi, Maria Letizia Bacchi Reggiani, more

Catheterization and Cardiovascular Interventions > 91 > 6 > E49 - E55

Objectives To define the incidence of vascular complications (VC) after balloon aortic valvuloplasty (BAV) in recent years, and to compare the performance of two vascular closure devices (VCD). Background VC remain the most frequent drawback of BAV and are associated with adverse clinical outcomes. Methods All BAV procedures performed at 2 high‐volume centers over a 6‐year period (n = 930) were...

article

Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding

Andrea Rubboli, Francesco Saia, Alessandro Sciahbasi, Antonio M. Leone, more

Cardiovascular Revascularization Medicine > 2017 > 18 > 6 > 425-430

To evaluate the outcome of patients with an established indication for oral anticoagulation (OAC) undergoing coronary stent implantation (PCI-S) and stratified by the baseline risk of bleeding.The database of the prospective, multicentre, observational WAR-STENT registry (ClinicalTrials.gov identifier NCT00722319) was analyzed and patients with atrial fibrillation and CHA₂DS₂-VASc score ≥2, mechanical...

article

Causes of Death in Patients ≥75 Years of Age With Non–ST-Segment Elevation Acute Coronary Syndrome

Nuccia Morici, Stefano Savonitto, Ernesto Murena, Roberto Antonicelli, more

The American Journal of Cardiology > 2013 > 112 > 1 > 1-7

The causes of death within 1 year of hospital admission in patients with non–ST-segment elevation acute coronary syndromes are ill defined, particularly in patients aged ≥75 years. From January 2008 through May 2010, we enrolled 645 patients aged ≥75 years with non–ST-segment elevation acute coronary syndromes: 313 in a randomized trial comparing an early aggressive versus an initially conservative...

article

Results from the REAL (REgistro Regionale AngiopLastiche Emilia-Romagna) multicenter registry

Paolo Ortolani, Emilia Solinas, Paolo Guastaroba, Gianni Casella, more

International Journal of Cardiology > 2011 > 149 > 1 > 55-62

The long-term effectiveness of drug eluting stents (DESs) in a real-world setting of female patients is currently unclear.We analyzed long-term follow-up (up to 3 years) data from all female patients with de novo lesions enrolled in a prospective web-based multicenter registry (REAL Registry; study period, July 2002–June 2006) including all 15 hospitals performing PCI in the Emilia-Romagna region...

article

Recurrent Tako-Tsubo cardiomyopathy with similar clinical and instrumental signs

Samuela Carigi, Andrea Santarelli, Federica Baldazzi, Daniele Grosseto, more

International Journal of Cardiology > 2011 > 148 > 2 > 256-257

article

Comparison of 2‐year clinical outcomes with sirolimus and paclitaxel‐eluting stents for patients with diabetes: Results of the Registro Regionale AngiopLastiche Emilia‐Romagna Registry

Marco Balducelli, Paolo Ortolani, Paolo Marzaroli, Giancarlo Piovaccari, more

Catheterization and Cardiovascular Interventions > 75 > 3 > 327 - 334

Background: Long‐term outcomes of percutaneous coronary interventions (PCI) with sirolimus‐eluting stents (SES) compared to paclitaxel‐eluting‐stents (PES) in unselected diabetics in routine practice is still debated. Objective: This study compared the 2‐year incidence of MACE (all‐cause mortality, nonfatal myocardial infarction and target vessel revascularization) of SES and PES in a real‐world setting...

article

Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention and Abciximab or Tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial)

Nevio Taglieri, Francesco Saia, Vincenzo Guiducci, Stefano Tondi, more

The American Journal of Cardiology > 2009 > 103 > 6 > 785-790

Abciximab therapy during primary percutaneous coronary intervention (PCI) has shown to ameliorate left ventricular (LV) function recovery in patients with ST elevated myocardial infarction. High-dose bolus tirofiban has similar effect on platelet inhibition. Whether this is associated with comparable efficacy on LV function recovery remains unclear. We sought to evaluate the impact on LV function...

article

Comparison of Drug-Eluting Stents and Bare-Metal Stents for the Treatment of Unprotected Left Main Coronary Artery Disease in Acute Coronary Syndromes

Corrado Tamburino, Maria Elena Di Salvo, Davide Capodanno, Tullio Palmerini, more

The American Journal of Cardiology > 2009 > 103 > 2 > 187-193

The aim of this study was to compare long term clinical outcome after left main stenting in a large real world population of patients treated with drug-eluting stents (DES) or bare-metal stents (BMS) in the setting of acute coronary syndromes. The advent of DES decreased the risk of unprotected left main coronary artery restenosis as compared with BMS, but safety concerns still exist, especially when...

article

Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry)

Luigi Vignali, Francesco Saia, Antonio Manari, Andrea Santarelli, more

The American Journal of Cardiology > 2008 > 101 > 7 > 947-952

Percutaneous revascularization of saphenous vein grafts (SVGs) remains a challenging task. Drug-eluting stents (DESs) have been shown to decrease the incidence of restenosis in de novo native coronary artery lesions. However, their clinical value in SVGs remains to be established. We compared long-term clinical outcomes of percutaneous coronary intervention with DESs and bare metal stents (BMSs) for...

article

Comparison of Two Antiplatelet Regimens (Aspirin Alone Versus Aspirin + Ticlopidine or Clopidogrel) After Intracoronary Implantation of a Carbofilm-Coated Stent

Antonio Luca Bartorelli, Corrado Tamburino, Daniela Trabattoni, Alfredo Galassi, more

The American Journal of Cardiology > 2007 > 99 > 8 > 1062-1066

Stent thrombosis (ST) is an infrequent (0.5% to 1.5%) complication of intracoronary stenting, with severe clinical consequences. This multicenter, randomized study evaluated the clinical outcome in 479 patients (598 lesions treated) who underwent elective coronary stenting with a Carbofilm-coated stent (CarboStent) who met prespecified eligibility criteria and were randomly assigned to receive aspirin...

article

Clinical Outcomes for Sirolimus-Eluting Stents and Polymer-Coated Paclitaxel-Eluting Stents in Daily Practice

Francesco Saia, Giancarlo Piovaccari, Antonio Manari, Andrea Santarelli, more

Journal of the American College of Cardiology > 2006 > 48 > 7 > 1312-1318

We compared the clinical outcome of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in a real-world scenario.In selected patients, SES has been associated with lower late luminal loss than PES. Whether this emerging biological difference could translate into different clinical efficacy in daily practice is presently unknown.This analysis included 1,676 consecutive patients with...

article

Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) Registry

Gianfranco Percoco, Antonio Manari, Paolo Guastaroba, Gianluca Campo, more

Cardiovascular Drugs and Therapy > 2006 > 20 > 1 > 63-68

Summary Background: Limited data are available for sirolimus eluting stent (SES) implantation in patients with ST-segment elevation myocardial infarction (STEMI). Aim: to confirm the safety and effectiveness of SES in patients with STEMI in a real-world scenario (multicentric registry). Methods: From July 2002 to June 2004, clinical and angiographic data of 1617 patients with STEMI treated...

article

Comparison of Effectiveness of Sirolimus-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Patients at High Risk for Coronary Restenosis or Clinical Adverse Events

Antonio Marzocchi, Giancarlo Piovaccari, Antonio Manari, Enrico Aurier, more

The American Journal of Cardiology > 2005 > 95 > 12 > 1409-1414

We evaluated the clinical effect of selective use of sirolimus-eluting stents (SESs) in real-world, high-risk patients. A total of 4,237 consecutive patients who underwent percutaneous coronary intervention (SES, n = 872, bare metal stents [BMSs], n = 3,365) was enrolled in a prospective regional survey. A prespecified high-risk subset of patients was selected on the basis of clinical and angiographic...

article

Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI)

Carlo Di Mario, Leonardo Bolognese, Luc Maillard, Dariusz Dudek, more

American Heart Journal > 2004 > 148 > 3 > 378-385

article

Results of coronary stenting for unstable versus stable angina pectoris

Antonio Marzocchi, Giancarlo Piovaccari, Cinzia Marrozzini, Paolo Ortolani, more

The American Journal of Cardiology > 1997 > 79 > 10 > 1314-1318

Coronary artery stenting has been shown to improve the short- and long-term results of coronary angioplasty in mainly stable patients with 1-vessel disease, but it is uncertain whether its use in an unstable clinical setting may be safe and useful. To evaluate the stenting efficacy in patients with unstable angina, we retrospectively examined our experience with the Palmaz-Schatz balloon expandable...

article

Dynamic planar myocardial perfusion imaging in patients with one-vessel disease with intracoronary injection of technetium 99m teboroxime during papaverine-induced coronary hyperemia

Flavio Tartagni, Francesco Fallani, Claudio Corbelli, Nino Monetti, more

American Heart Journal > 1996 > 132 > 5 > 1042-1047

This study examined the imaging results and kinetics of technetium 99m teboroxime after its intracoronary injection during papaverine-induced coronary hyperemia in patients with one-vessel disease before and after coronary angioplasty. Thirteen patients with >=90% diameter stenosis of either the left anterior descending or the left circumflex coronary artery were included. Two patients were excluded...

article

Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up

Giancarlo Piovaccari, Rossella Maria Ferretti, Francesco Prati, Anna Maria Traini, more

International Journal of Cardiology > 1995 > 49 > 1 > 39-43

Occult or overt but delayed cardiac disease after thoracic radiotherapy for Hodgkin's disease may be common. Detailed cardiac evaluation was performed in 108 patients, mean age 46 ± 6.2 years, with Hodgkin's disease at 175 ± 43 months after irradiation. The study protocol included clinical examination, graded treadmill exercise test and echocardiography. Some patients with angina pectoris, previous...

Filter options

Publication date

Set your own date range

INFONA - science communication portal

Search results for: Giancarlo Piovaccari

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Content availability

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options